Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
Author:
Affiliation:
1. Bone Marrow Transplant Program and
2. Departments of Medicine,
3. Pediatrics,
4. Pathology, and
5. Microbiology, Medical College of Wisconsin, Milwaukee; and
6. Chugai Pharmaceuticals, Shizuoka, Japan
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/114/4/891/1321792/zh803009000891.pdf
Reference59 articles.
1. Total body irradiation and acute graft versus host disease: the role of gastrointestinal damage and inflammatory cytokines.;Hill;Blood,1997
2. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft versus host disease in H-2 incompatible transplanted SCID mice.;Xun;Blood,1994
3. Pathophysiology of graft versus shot disease.;Ferrara;Semin Hematol,2006
4. Acute graft versus host disease does not require alloantigen expression on host epithelium.;Teshima;Nat Med,2002
5. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft versus host disease.;Mowat;Immunology,1989
Cited by 248 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. IL-6 trans-signaling in a humanized mouse model of scleroderma;Proceedings of the National Academy of Sciences;2023-09-05
2. MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATION;2023-08-14
3. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis;TRANSPL CELL THER;2023
4. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis;Transplantation and Cellular Therapy;2023-08
5. Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms;European Journal of Pharmacology;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3